Wepon Pharmaceutical Holding Group Co Ltd

Chart & Performance

D1W1MN

P/E

137.03

P/S

5.26

EPS

0.09

Div Yield, %

0.64%

Shrs. gr., 5y

20.78%

Rev. gr., 5y

-38.03%

Revenues

1.44b

-6.39%

Net income

55m

+12.66%

CFO

120m

Dividend

Jul 11, 20240.08 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research, development, production, and sale of Chinese medicines, APIs, and preparations. It also develops medical devices, including orthopaedic implant devices, medical equipment, and protective equipment, as well as disposable bacteria medical polymer consumables; and provides hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is based in Taizhou, China.

URL

https://www.dongliang.com.cn/

IPO date

Nov 20, 2006

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT